Breathing Muscle Training for Severe Obesity and Sleep Apnea
Tests a 12-week breathing muscle training program in adults with severe obesity and sleep apnea.
Key facts
- Who runs it
- University of the State of Santa Catarina
- Where
- Florianópolis, BrazilSee the site
- Trial code
- Registry title
- High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea
- Status
- Not yet recruiting
- People taking part
- 10 people, planned
- Started
- 1 May 2026
- Expected to end
- 1 Dec 2027
- Type of study
- Interventional
- Treatments tested
- High-Intensity Progressive Inspiratory Muscle Training (IMT)
- Record updated
- 23 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe obesity (BMI above 40 kg/m²) and obstructive sleep apnea. They will do 12 weeks of daily breathing muscle training with a hand-held device.
- Age
- 18 years or older
- Sex
- Women and men can join
- Disease stage
- Class III obesity (BMI above 40 kg/m²) and a diagnosis of obstructive sleep apnea (OSA)
- Earlier treatment
- People currently using CPAP therapy cannot join.
Main reasons for not taking part
- Lung, heart or kidney disease or other body-wide disease
- Using medicines that may affect muscle performance
- Currently using CPAP therapy
- Nerve or brain conditions that prevent answering the study assessments
- Conditions that could make it hard to follow the study plan
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Of both genders
- Class III obesity (BMI > 40 kg/m²)
- Diagnosis of OSA
- Without neurological conditions that would prevent them from responding to the study assessments
Who cannot take part
- Are using medications that may affect muscle performance
- Are currently using CPAP therapy
- Systemic diseases (pulmonary, cardiac or renal)
- Conditions that could compromise adherence to the study protocol
Where in Brazil
- Santa Catarina State University - CEFID (Center of Health and Sport Sciences)Florianópolis, BrazilContact: Karina Abreu, MScNo longer taking part
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the feasibility and effects of a 12-week high-intensity progressive Inspiratory Muscle Training (IMT) program in individuals with Class III obesity (BMI ≥ 40 kg/m²) and obstructive sleep apnea (OSA). Using a single-case experimental design (SCED) with multiple baselines, the study will investigate whether this respiratory intervention can reduce the severity of sleep apnea, as measured by the Apnea-Hypopnea Index (AHI), and improve inspiratory muscle strength and sleep quality. Participants will perform daily training sessions using a resistive loading device (POWERbreathe), with intensity progressing from 40% to 90% of their maximum inspiratory pressure.
The group in the trial
- Experimental Group: High-Intensity IMTTreatment being tested
Participants will undergo a progressive high-intensity Inspiratory Muscle Training (IMT) program using a resistive loading device (POWERbreathe).
Treatment: High-Intensity Progressive Inspiratory Muscle Training (IMT)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea: Study Protocol for a Prospective Nonconcurrent Multiple-Baseline Single-Case Experimental Design With Stability-Based Phase Transition
- Plain-language title
- Breathing Muscle Training for Severe Obesity and Sleep ApneaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 23 March 2026